Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Genitourinary Radiology: Page 36
Societies eye role for prostate MRI-guided biopsy
By
AuntMinnie.com staff writers
The American Urological Association and the Society of Abdominal Radiology are recommending the use of MRI and MRI-targeted biopsy in monitoring patients for prostate cancer after a negative biopsy.
December 5, 2016
Study: Gonadal shielding cuts radiation dose
By
AuntMinnie.com staff writers
Using a flat contact shield during imaging of the adult male pelvis can result in statistically significant radiation dose reduction to the testes, according to a new study in
Radiologic Technology
.
November 29, 2016
NPV is a key indicator for future prostate cancer risk
By
Wayne Forrest
CHICAGO - Negative predictive values (NPVs) derived from multiparametric MRI scans provide an excellent indication of clinically significant prostate cancer and could help men with a prior negative biopsy avoid unnecessary procedures, according to a study presented on Tuesday at RSNA 2016.
November 28, 2016
Prostate CAD boosts detection for most readers
By
Eric Barnes
CHICAGO - MRI-based computer-aided detection (CAD) can improve detection sensitivity for prostate cancer for most readers, while reducing reading time fourfold, according to a Tuesday presentation at RSNA 2016.
November 28, 2016
Blue Earth PET radiotracer IDs prostate cancer recurrence
By
AuntMinnie.com staff writers
Radiopharmaceutical developer Blue Earth Diagnostics is highlighting results from a phase III clinical trial of its Axumin (fluciclovine F-18) PET radiopharmaceutical agent indicating a 68% detection rate for prostate cancer recurrence.
October 23, 2016
PET, MRI may aid prostate cancer treatment
By
AuntMinnie.com staff writers
Using carbon-11 choline PET and multiparametric MRI, Mayo Clinic researchers may have found a way to improve postsurgery treatment of patients with recurrent prostate cancer, according to a study published online in the
Journal of Urology
.
October 4, 2016
Shortened RT works for low-risk prostate cancer patients
By
AuntMinnie.com staff writers
A shortened, higher-dose radiation therapy (RT) protocol is safe for low-risk prostate cancer patients and is associated with lower costs and similar quality-of-life outcomes, according to research presented at the recent American Society for Radiation Oncology meeting in Boston.
October 3, 2016
Contrast use doesn't change acute kidney injury rate
By
Eric Barnes
The use of contrast media in x-ray and CT exams is probably less harmful to the kidneys than previously thought, and clinicians should reconsider the wisdom of withholding important imaging exams based on their use of contrast, even in individuals at risk, concludes a just-published study in the
Journal of the American Society of Nephrology
.
September 28, 2016
UC-Care releases MR/TRUS prostate biopsy system
By
AuntMinnie.com staff writers
Israeli medical device firm UC-Care has introduced its Navigo MR/transrectal ultrasound (TRUS) fusion biopsy device for prostate cancer.
September 25, 2016
ASTRO: Prostate cancer has 3 molecular subtypes
By
AuntMinnie.com staff writers
Prostate cancer comes in three distinct molecular subtypes, each of which correlates with distant metastasis-free survival, according to a presentation at the American Society for Radiation Oncology (ASTRO) meeting in Boston.
September 25, 2016
MR/TRUS fusion biopsy targets high-risk prostate cancer
By
Erik L. Ridley
Targeted prostate biopsies guided by fused MR and transrectal ultrasound (TRUS) images can detect more cases of aggressive prostate cancer than traditional systematic biopsies guided by TRUS alone, according to a multicenter study published recently in
Urologic Oncology: Seminars and Original Investigations
.
September 19, 2016
Prostate cancer rates decline after USPSTF change
By
AuntMinnie.com staff writers
Rates of early prostate cancer have continued to decline since the U.S. Preventive Services Task Force (USPSTF) recommended against routine prostate-specific antigen testing in all men in 2012, according to an article published online August 18 in
JAMA Oncology
.
August 18, 2016
Previous Page
Page 36 of 93
Next Page